Kocitaf 50mg/200mg/25mg Tablet is unsafe to use in individuals with liver disease and may be avoided.This revolutionary drug is mostly becoming explored for its prospective purpose in oncology, particularly focusing on several different types of cancer. Researchers can also be investigating its software in autoimmune diseases, aiming to leverage it